Trial Profile
A Single Dose, Within Subject, 3 Period, Pharmacokinetic Bridging Study of CoFactor Formulations and of Leucovorin Administered Intravenously in Healthy, Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Folitixorin (Primary) ; Folinic acid
- Indications Breast cancer; Colorectal cancer; Pancreatic cancer
- Focus Pharmacokinetics
- Sponsors Mast Therapeutics
- 23 Sep 2008 New trial record.